← Back to all earnings calls

Serina Therapeutics, Inc. Q3 FY2022 Earnings Call

Serina Therapeutics, Inc. (SER)

Earnings Call FY2022 Q3 Call date: 2022-11-10 Concluded

Share

Quarter scorecard

Revenue

$9,000

-62.5% YoY

Diluted EPS

$-2.14

Gross margin

44.4%

-47.3 pp YoY

Net income

$

Documents & deck